-
Zika Coming: Some of U.S. Lacks Mosquito Control
Mosquitoes carrying the Zika virus could be a problem in most states this year. At the same time, nearly half the country lacks any kind of mosquito control.
-
Contaminated Eye Ointments Recalled by Allergan
Allergan is voluntarily recalling certain lots of various eye ointments because some users said they were contaminated, the pharmaceutical company announced.
-
FDA OKs OxyContin for Some Children
The FDA has approved the use of OxyContin in children ages 11 to 16 with severe pain, the agency says on its web site.
-
FDA Approves Combo Hepatitis C Treatment
FDA Approves Combo Hepatitis C Treatment
-
FDA Approves New Drug for Advanced Ovarian Cancer
Agency also gives OK to genetic test used to identify eligible patients
-
FDA Approves New Drug to Combat Melanoma
Advocates for melanoma research are applauding the U.S. Food and Drug Administration's approval on Thursday of a new drug to treat advanced melanoma.
-
Newer Drug Helps Older Myeloma Patients
Treatment may extend survival for patients over 65, researchers say
-
FDA OKs New Once-Daily Asthma Treatment
The FDA has approved Arnuity Ellipta (fluticasone furoate inhalation powder), an inhaled steroid taken once a day to prevent asthma symptoms in people 12 and older, drugmaker GlaxoSmithKline says.
-
FDA Approves New Kind of Insomnia Drug
Belsomra acts on brain chemicals that regulate your sleep-wake cycle
-
Orbactiv OK'd for Drug-Resistant Skin Infections
Third such antibiotic sanctioned this year
Find a Drug:
by name or medical condition or shape/color (Pill Identifier)